Literature DB >> 10891974

beta-peptide immunization: a possible new treatment for Alzheimer disease.

D B Schenk1, P Seubert, I Lieberburg, J Wallace.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10891974     DOI： 10.1001/archneur.57.7.934

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  11 in total

1.  Vaccine trial in Alzheimer's disease is halted.

Authors:  Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

Review 2.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

3.  Drug discovery for Alzheimer's disease: the end of the beginning.

Authors:  Lorenzo M Refolo; Howard M Fillit
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 4.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

5.  Decrease in neuroinflammation after immunisation with synthetic prion peptides in an animal model of scrapie.

Authors:  F Servida; C Ravasi; M Puricelli; E A M Formentin; P Dall'Ara; G Poli
Journal:  Vet Res Commun       Date:  2007-08       Impact factor: 2.459

Review 6.  Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization.

Authors:  D Schenk; D Games; P Seubert
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

Review 7.  Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

Authors:  Harald Hampel; Yong Shen; Dominic M Walsh; Paul Aisen; Les M Shaw; Henrik Zetterberg; John Q Trojanowski; Kaj Blennow
Journal:  Exp Neurol       Date:  2009-10-06       Impact factor: 5.330

Review 8.  New pathways in drug discovery for Alzheimer's disease.

Authors:  Eric R Siemers; Robert A Dean; Ronald Demattos; Patrick C May
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

9.  Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives.

Authors:  Yanming Wang; Chester A Mathis; Guo-Feng Huang; Manik L Debnath; Daniel P Holt; Li Shao; William E Klunk
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

10.  Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease.

Authors:  Yanming Wang; William E Klunk; Guo-Feng Huang; Manik L Debnath; Daniel P Holt; Chester A Mathis
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.